Back to Search
MARK POMERANTZ, MD
MD
Internal Medicine Physician
NPI: 1194701599IndividualAccepts Medicare
Specialties, Licenses & Credentials
Education
STANFORD UNIVERSITY SCHOOL OF MEDICINE
Class of 2001
Research & Publications (17)
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.
PMID 19561607·Nat Genet·2009
8-other
Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
PMID 19549893·Cancer Res·2009
8-other
Phase II study of low dose and high dose conjugated estrogen for androgen independent prostate cancer.
PMID 17509304·J Urol·2007
3-trial
Evaluation of 8q24 and 17q risk loci and prostate cancer mortality.
PMID 19366828·Clin Cancer Res·2009
4-observational
Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy.
PMID 19152438·Cancer·2009
8-other
Anatomic lung resection for nontuberculous mycobacterial disease.
PMID 18498789·Ann Thorac Surg·2008
8-other
Native lung volume reduction surgery relieves functional graft compression after single-lung transplantation for chronic obstructive pulmonary disease.
PMID 18374782·J Thorac Cardiovasc Surg·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 55 FRUIT ST YAW 7604, MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA 02114 - Phone
- (617) 724-2241
Quick Facts
- NPI
- 1194701599
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 25
- Publications
- 17
Are you this provider?
Claim Your Profile